rs972548690
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2
The NM_001350451.2(RBFOX3):c.1002C>T(p.Tyr334Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000324 in 1,143,614 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.000035 ( 0 hom., cov: 29)
Exomes 𝑓: 0.000032 ( 0 hom. )
Consequence
RBFOX3
NM_001350451.2 synonymous
NM_001350451.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.169
Publications
1 publications found
Genes affected
RBFOX3 (HGNC:27097): (RNA binding fox-1 homolog 3) This gene encodes a member of the RNA-binding FOX protein family which is involved in the regulation of alternative splicing of pre-mRNA. The protein has an N-terminal proline-rich region, an RNA recognition motif (RRM) domain, and a C-terminal alanine-rich region. This gene produces the neuronal nuclei (NeuN) antigen that has been widely used as a marker for post-mitotic neurons. This gene has its highest expression in the central nervous system and plays a prominent role in neural tissue development and regulation of adult brain function. Mutations in this gene have been associated with numerous neurological disorders. Alternative splicing of this gene results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, May 2017]
RBFOX3 Gene-Disease associations (from GenCC):
- epilepsyInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 17-79094526-G-A is Benign according to our data. Variant chr17-79094526-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 700707.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-0.169 with no splicing effect.
BS2
High AC in GnomAd4 at 5 AD gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| RBFOX3 | NM_001350451.2 | c.1002C>T | p.Tyr334Tyr | synonymous_variant | Exon 14 of 15 | ENST00000693108.1 | NP_001337380.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| RBFOX3 | ENST00000693108.1 | c.1002C>T | p.Tyr334Tyr | synonymous_variant | Exon 14 of 15 | NM_001350451.2 | ENSP00000510395.1 |
Frequencies
GnomAD3 genomes AF: 0.0000352 AC: 5AN: 141898Hom.: 0 Cov.: 29 show subpopulations
GnomAD3 genomes
AF:
AC:
5
AN:
141898
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000172 AC: 1AN: 58164 AF XY: 0.00 show subpopulations
GnomAD2 exomes
AF:
AC:
1
AN:
58164
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000319 AC: 32AN: 1001716Hom.: 0 Cov.: 29 AF XY: 0.0000247 AC XY: 12AN XY: 485258 show subpopulations
GnomAD4 exome
AF:
AC:
32
AN:
1001716
Hom.:
Cov.:
29
AF XY:
AC XY:
12
AN XY:
485258
show subpopulations
African (AFR)
AF:
AC:
1
AN:
16900
American (AMR)
AF:
AC:
0
AN:
7390
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
12774
East Asian (EAS)
AF:
AC:
0
AN:
6684
South Asian (SAS)
AF:
AC:
0
AN:
58730
European-Finnish (FIN)
AF:
AC:
0
AN:
22376
Middle Eastern (MID)
AF:
AC:
0
AN:
3296
European-Non Finnish (NFE)
AF:
AC:
31
AN:
837566
Other (OTH)
AF:
AC:
0
AN:
36000
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0000352 AC: 5AN: 141898Hom.: 0 Cov.: 29 AF XY: 0.0000437 AC XY: 3AN XY: 68702 show subpopulations
GnomAD4 genome
AF:
AC:
5
AN:
141898
Hom.:
Cov.:
29
AF XY:
AC XY:
3
AN XY:
68702
show subpopulations
African (AFR)
AF:
AC:
3
AN:
38952
American (AMR)
AF:
AC:
0
AN:
14258
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3334
East Asian (EAS)
AF:
AC:
0
AN:
4098
South Asian (SAS)
AF:
AC:
0
AN:
4026
European-Finnish (FIN)
AF:
AC:
0
AN:
8920
Middle Eastern (MID)
AF:
AC:
0
AN:
298
European-Non Finnish (NFE)
AF:
AC:
2
AN:
65160
Other (OTH)
AF:
AC:
0
AN:
1976
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.535
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Idiopathic generalized epilepsy Benign:1
Nov 07, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.